|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 189.88 INR | -1.07% |
|
-2.48% | -23.31% |
| 26/05 | Dishman Carbogen Amcis Limited, Q4 2026 Earnings Call, May 20, 2026 | |
| 19/05 | Dishman Carbogen Amcis Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| Capitalization | 2.04TCr 21Cr 19Cr 17Cr 16Cr 30Cr 30Cr 201.97Cr 79Cr 985.45Cr 80Cr 79Cr 3.43TCr | P/E ratio 2024 |
-24.1x | P/E ratio 2025 | 1,054x |
|---|---|---|---|---|---|
| Enterprise value | 3.91TCr 41Cr 36Cr 33Cr 31Cr 57Cr 58Cr 387.84Cr 150.94Cr 1.89TCr 154.18Cr 150.83Cr 6.58TCr | EV / Sales 2024 |
2.13x | EV / Sales 2025 | 1.95x |
| Free-Float |
30.7% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Dishman Carbogen Amcis Limited
| 1 day | -1.07% | ||
| 1 week | -2.48% | ||
| Current month | -2.48% | ||
| 1 month | +2.01% | ||
| 3 months | +15.31% | ||
| 6 months | -14.78% | ||
| Current year | -23.31% |
| 1 week | 188.9 | 202 | |
| 1 month | 173.8 | 224.4 | |
| Current year | 128.5 | 267 | |
| 1 year | 128.5 | 321.95 | |
| 3 years | 123.3 | 321.95 | |
| 5 years | 80 | 321.95 | |
| 10 years | 46.05 | 396.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 40 | 07/02/2019 | |
Harshil R. Dalal
DFI | Director of Finance/CFO | 44 | 28/11/2018 |
Paolo Armanino
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 75 | 17/03/2017 | |
| Director/Board Member | 40 | 17/03/2017 | |
| Director/Board Member | - | 13/11/2024 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.07% | -2.48% | -30.55% | +53.13% | 31Cr | ||
| +0.55% | +2.39% | +47.77% | +154.68% | 1,00900Cr | ||
| +2.02% | +3.30% | +51.48% | +47.03% | 56TCr | ||
| +1.02% | +4.37% | +21.21% | +66.03% | 40TCr | ||
| +0.77% | -0.67% | +22.19% | +12.23% | 33TCr | ||
| +2.24% | +0.41% | +29.51% | +17.50% | 29TCr | ||
| +1.85% | +0.14% | +22.04% | +30.54% | 27TCr | ||
| +4.43% | -3.11% | -40.46% | -47.48% | 19TCr | ||
| +1.15% | +3.80% | +21.76% | +57.55% | 19TCr | ||
| -0.02% | -3.92% | +16.93% | +66.19% | 16TCr | ||
| Average | +0.95% | +0.80% | +16.19% | +45.74% | 34.02TCr | |
| Weighted average by Cap. | +0.63% | +1.96% | +31.24% | +70.11% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.62TCr 27Cr 24Cr 22Cr 21Cr 38Cr 39Cr 259.26Cr 100.9Cr 1.27TCr 103.07Cr 100.83Cr 4.4TCr | 2.71TCr 28Cr 25Cr 23Cr 21Cr 40Cr 40Cr 268.75Cr 104.59Cr 1.31TCr 106.84Cr 104.52Cr 4.56TCr |
| Net income | -153.45Cr -1.61Cr -1.39Cr -1.28Cr -1.2Cr -2.24Cr -2.28Cr -15Cr -5.92Cr -74Cr -6.05Cr -5.91Cr -258.07Cr | 3.24Cr 3L 3L 3L 3L 5L 5L 32.11L 12.5L 1.57Cr 12.77L 12.49L 5.45Cr |
| Net Debt | 1.88TCr 20Cr 17Cr 16Cr 15Cr 27Cr 28Cr 186.46Cr 73Cr 909.77Cr 74Cr 73Cr 3.16TCr | 1.88TCr 20Cr 17Cr 16Cr 15Cr 27Cr 28Cr 185.87Cr 72Cr 906.94Cr 74Cr 72Cr 3.15TCr |
Employees
1,106
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/26/05 | 189.88 ₹ | -1.07% | 1,85,064 |
| 04/26/04 | 191.94 ₹ | -1.63% | 2,08,341 |
| 03/26/03 | 195.13 ₹ | -1.99% | 2,01,753 |
| 02/26/02 | 199.10 ₹ | +1.78% | 2,24,671 |
| 01/26/01 | 195.62 ₹ | +0.47% | 2,15,093 |
Annual profits - Rate of surprise
- Stock Market
- Equities
- DCAL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition

















